Академический Документы
Профессиональный Документы
Культура Документы
We are asked to sell our rights in the Board Room for $10 Million. We are asked to go
against the wisdom of the original demutualization document. We are asked to
eliminate nearly one-third of the existing Board of Directors, all of whom specifically
represent B Shareholders. We believe that CME has a fundamental duty to its B
Shareholders concerning proper equitable valuation.
While we agree this action may be in the interests of the future of CME Group globally,
the question of valuation should be determined by a mutually agreed upon financial
third-party analyst. When CME group and the B Shareholders come to an agreed upon
valuation, we should proceed with the proxy vote.
As of now, the current proposal stands without our input. It behooves all B Shareholders
to vote NO.
*CME Group Notice to Class B Shareholders and our Members August 23,2018